« Previous article
Luminex Submits ARIE...
Luminex Submits ARIE...
Next article »
New ambr® 250 Mo...
New ambr® 250 Mo...
2nd July 2019 Content supplied by: ViroStat Inc.
NEW Monoclonal Antibodies to Gardnerella vaginalis
Gardnerella vaginalis is a major species present in bacterial vaginosis. It is a small gram variable, anaerobic coccobacillus. Overgrowth of this bacterium occurs due to an imbalance of normal vaginal flora which can result from prescription antibiotics.
Microscopic evaluation often shows this bacterium associated with epithelial “clue cells”. Treatment with metronidazole or clindamycin is recommended.
ViroStat has just released a set of new monoclonal antibodies to Gardnerella vaginalis. These specific antibodies do not cross react with other agents including Chlamydia, Candida albicans and Neisseria gonorrhoeae. Several of the antibodies function as pairs in ELISA and lateral flow immunoassay for antigen detection.
Please note : Any products described on this page are
for Research Use Only and not intended for clinical diagnostic procedures unless otherwise stated.
Tags:
Date Published: 2nd July 2019
« Previous article
Luminex Submits ARIES MRSA Assay
Luminex Submits ARIES MRSA Assay
Next article »
New ambr® 250 Modular Bioreactor
New ambr® 250 Modular Bioreactor